Stockreport

Kerecis included on the list of covered products for Diabetic Foot Ulcers in the final LCD policy [Yahoo! Finance]

COLOPLAST AS SP/ADR  (CLPBY) 
NASDAQ:AMEX Investor Relations: coloplast.com/investor-relations
PDF substitute grafts/cellular and tissue-based products for the treatment of Diabetic Foot Ulcers (DFUs) and venous leg ulcers (VLUs) in the Medicare population. The fina [Read more]